ICCC

ImmuCell Corporation (ICCC) SWOT Analysis Analysis (2026)

Invetso Score: 5/10 — Balanced · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Strengths

Score: 5.8 (Moderate)

ROIC of 8.1% indicates ICCC is generating acceptable capital returns, but the level remains below stronger peer franchises with more durable economic moats.

A current ratio of 4.75 and quick ratio of 2.71 suggest liquidity is materially stronger than leveraged peers, supporting operational resilience through demand volatility.

Debt-to-equity of 0.40 implies a comparatively conservative balance sheet, which can preserve flexibility versus more indebted competitors in the same market.

The company’s net debt to EBITDA of 1.01 is manageable, indicating leverage is not yet a structural constraint relative to peers with heavier refinancing risk.

Weaknesses

Score:

Cash conversion cycle of 159.5 days is long, implying working-capital intensity that can lag peers with faster inventory and receivables turnover.

ROIC at 8.1% is only modestly above typical capital costs, limiting evidence of a durable value-creation advantage versus higher-return peers.

The absence of disclosed margin metrics in the provided data reduces visibility into operating efficiency, which weakens comparability against peers with clearer margin leadership.

Leverage is manageable, but net debt to EBITDA above 1.0 still leaves ICCC less flexible than net-cash peers when funding growth or absorbing shocks.

Opportunities

Score:

Improving working-capital discipline could shorten the 159.5-day cash conversion cycle, releasing cash faster than peers with similarly long operating cycles.

If management lifts ROIC above the current 8.1% level, ICCC could narrow the gap to stronger peers and improve long-term capital allocation efficiency.

The strong liquidity position provides room to fund selective expansion or customer support initiatives more comfortably than constrained competitors.

Moderate leverage leaves capacity to refinance or optimize the capital structure if market conditions remain favorable relative to more highly levered peers.

Threats

Score:

Peers with faster cash conversion cycles can reinvest capital more quickly, creating a structural operating advantage that ICCC currently does not match.

If working-capital intensity persists, the long cash cycle may continue to suppress free cash flow relative to competitors with leaner operations.

Any deterioration in demand could pressure a balance sheet that is currently sound but not as defensive as net-cash peers.

Without stronger return and margin evidence, ICCC risks remaining a middle-tier operator while peers with superior efficiency compound advantages over time.

Overall Score

Score:

ICCC appears financially stable with adequate returns and liquidity, but its long cash cycle and only moderate capital efficiency leave it positioned around the peer middle.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on ImmuCell Corporation. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →